1. Home
  2. HCWB vs CYAB Comparison

HCWB vs CYAB Comparison

Compare HCWB & CYAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$2.91

Market Cap

5.0M

Sector

Health Care

ML Signal

HOLD

Logo Cyabra Inc. Common Stock

CYAB

Cyabra Inc. Common Stock

N/A

Current Price

$0.36

Market Cap

5.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HCWB
CYAB
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.9M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
HCWB
CYAB
Price
$2.91
$0.36
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
117.7K
9.4M
Earning Date
05-15-2026
04-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,099,750.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.25
52 Week High
$6.11
$2.99

Technical Indicators

Market Signals
Indicator
HCWB
CYAB
Relative Strength Index (RSI) 47.53 56.32
Support Level $2.35 $0.26
Resistance Level $4.12 $0.50
Average True Range (ATR) 0.44 0.07
MACD 0.07 0.02
Stochastic Oscillator 44.63 38.08

Price Performance

Historical Comparison
HCWB
CYAB

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

About CYAB Cyabra Inc. Common Stock

Cyabra Inc is an AI-powered SaaS company that detects and analyzes online disinformation. Its platform uses machine learning to monitor social media and news data in real time, identify fake accounts and harmful narratives, and assess content authenticity and sentiment.

Share on Social Networks: